This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI HUMAN HIF1 ALPHA:Biotin
catalog :
MCA5695B
quantity :
0.1 mg
clonality :
monoclonal
host :
mouse
conjugate :
biotin
clone name :
ESEE122
reactivity :
human
application :
western blot, ELISA
product information
Entity Category :
Antibodies
Product Code :
MCA5695B
Description :
MOUSE ANTI HUMAN HIF1 ALPHA:Biotin
Specificity :
HIF1 ALPHA
Target Species :
Human
Host :
Mouse
Format :
Biotin
Conjugate/Tag :
Biotin
Isotypes :
IgG1
Applications :
E, P*, WB
Application Types :
Immunohistology - Paraffin, Western Blotting, ELISA
Clone :
ESEE122
Quantity :
0.1 mg
Quantity Value :
0.1 mg
Quantity Type :
mg
GO Accessions :
GO:0001666, GO:0001837, GO:0001938, GO:0002248, GO:0003677, GO:0003705, GO:0004871, GO:0005737, GO:0005667, GO:0005730, GO:0008134, GO:0051879, GO:0010575, GO:0010634, GO:0046886, GO:0030528, GO:0030949, GO:0032364, GO:0032722, GO:0032909, GO:0032963, GO:0035035, GO:0042789, GO:0043193, GO:0043619, GO:0045648, GO:0045766, GO:0045821, GO:0045944, GO:0046982, GO:0051000, GO:0051541
GO Terms :
activation of angiogenesis, activation of chemokine production, activation of endothelial cell proliferation, activation of erythrocyte differentiation, activation of gene-specific transcription, activation of glycolysis, activation of hormone biosynthetic process, activation of nitric-oxide synthase activity, activation of transcription from RNA polymerase II promoter, activation of vascular endothelial growth factor receptor signaling pathway, collagen metabolism, connective tissue replacement during inflammatory response, elastin metabolism, EMT, epithelial-mesenchymal transition, fibrosis during inflammatory response, GO:0005062, GO:0009369, GO:0009370, gp130, hematopoietin/interferon-class (D200-domain) cytokine receptor signal transducer activity, histone acetylase binding, Hsp90 binding, Hsp90 class protein binding, microtubule/chromatin interaction, mRNA transcription from Pol II promoter, nitric-oxide synthase activator, NOS activator, plasmid binding, positive regulation of hormone anabolism, positive regulation of hormone biosynthesis, positive regulation of hormone formation, positive regulation of hormone synthesis, positive regulation of NOS activity, positive regulation of RBC differentiation, positive regulation of red blood cell differentiation, positive regulation of transcription from Pol II promoter, positive regulation of vascular endothelial growth factor receptor signalling pathway, positive regulation of VEGF receptor signaling pathway, positive regulation of VEGF receptor signalling pathway, quorum sensing response regulator activity, quorum sensing signal generator activity, regulation of TGFB2 production, regulation of TGF-B2 production, response to hypoxic stress, response to lowered oxygen tension, stimulation of angiogenesis, stimulation of chemokine production, stimulation of endothelial cell proliferation, stimulation of erythrocyte differentiation, stimulation of gene-specific transcription, stimulation of glycolysis, stimulation of hormone biosynthetic process, stimulation of nitric-oxide synthase activity, stimulation of transcription from RNA polymerase II promoter, stimulation of vascular endothelial growth factor receptor signaling pathway, TF binding, transcriptional regulator activity, up regulation of angiogenesis, up regulation of chemokine production, up regulation of endothelial cell proliferation, up regulation of erythrocyte differentiation, up regulation of gene-specific transcription, up regulation of glycolysis, up regulation of hormone biosynthetic process, up regulation of nitric-oxide synthase activity, up regulation of transcription from RNA polymerase II promoter, up regulation of vascular endothelial growth factor receptor signaling pathway, upregulation of angiogenesis, up-regulation of angiogenesis, upregulation of chemokine production, up-regulation of chemokine production, upregulation of endothelial cell proliferation, up-regulation of endothelial cell proliferation, upregulation of erythrocyte differentiation, up-regulation of erythrocyte differentiation, up-regulation of gene-specific transcription, upregulation of gene-specific transcription, upregulation of glycolysis, up-regulation of glycolysis, upregulation of hormone biosynthetic process, up-regulation of hormone biosynthetic process, up-regulation of nitric-oxide synthase activity, upregulation of nitric-oxide synthase activity, upregulation of transcription from RNA polymerase II promoter, up-regulation of transcription from RNA polymerase II promoter, upregulation of vascular endothelial growth factor receptor signaling pathway, up-regulation of vascular endothelial growth factor receptor signaling pathway
Uniprot Accessions :
Q16665
Gene :
HIF1A
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3091
Published Synonyms :
HYPOXIA-INDUCIBLE FACTOR 1-ALPHA
EntityFormats :
Purified, Biotin
UNSPSC :
41116161
Concentration :
IgG concentration 0.1 mg/ml
Product Form :
Purified IgG conjugated to Biotin - liquid
PrimarySecondary :
Primary
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.